SOSV

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Moirai Biodesign develops RNA-based therapies and diagnostics for cancer. The company develops non-invasive tests for in-vitro and in-situ diagnosis of AML using the patients blood; in-vivo diagnosis systems for surgical assistance and patient monitoring; and therapeutical drugs for treating cancer. Its pipeline includes RNA biomarker discovery, plug and play bio device design, and platform delivery system. The company was founded in 2016 and is based in Ireland.

Midoconline is a telehealth company focused on enhancing wellness through improved access to medical care and preventative measures. It offers a platform that enables patients to connect with healthcare professionals via video consultations, facilitating remote medical advice for non-emergency issues. The mobile application serves as a convenient tool for users seeking medical consultations, thereby promoting better health management and accessibility to healthcare services.

Sava is a company focused on advancing biosensing technology to enhance personal health monitoring. By providing real-time feedback on the body's molecular signature, particularly for athletes, Sava's technology allows for continuous and effortless monitoring of crucial metrics such as glucose and lactate levels. This capability enables athletes to train more effectively, predict fatigue, and optimize their dietary plans. Sava's innovative approach aims to make health information more accessible, delivering insights in a painless and affordable manner, thereby redefining how individuals interact with their health.

Impedans provide you with intelligent sensing platforms for radio-frequency (RF) and plasma process monitoring. Their products find applications in fundamental research, process development, tool design, process control and fault detection and classification (FDC). They serve a wide range of industries, due to the ubiquitous nature of RF and plasma processing, such as semiconductor, vacuum coating, medical device, hard disk and aerospace among many others. Their value proposition is that They provide you with an independent diagnosis of your process health, using intelligent, internet enabled sensing platforms, in conjunction with their vast experience in RF and plasma systems, to help you solve the most complex processing issues.

Ria Health is a telehealth provider focused on treating alcohol use disorders through a mobile platform. Founded in 2013 and based in San Francisco, California, the company connects users with addiction specialists for personalized support and guidance. Ria Health employs evidence-based protocols, including medication-assisted treatment, harm reduction, and cognitive behavioral therapy, to assist heavy drinkers seeking to reduce or stop their alcohol consumption. The Ria app facilitates secure, HIPAA-compliant interactions, allowing for video and phone consultations, breathalyzer measurements, and progress tracking. By offering a private and convenient treatment option, Ria Health aims to address the significant gap in care for individuals struggling with alcohol-related issues, ensuring effective and affordable support that aligns with payer objectives.

BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research. The company's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits. BioLumen was founded on 2018 and is headquartered in San Francisco, California.

Aksense is an innovative company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. Its flagship product is the first portable rapid infection diagnostic biosensor designed to improve healthcare quality and safety. By facilitating early detection and treatment of infections, Aksense's technology aims to enhance antibiotic prescribing practices and reduce the spread of infections. This approach not only improves patient outcomes but also supports public health initiatives by allowing users to recover faster through cost-effective molecular testing solutions.

AnimalBiome focuses on improving the gut health of dogs and cats in the United States that suffer from chronic digestive disorders. The company offers microbiome-based supplements and non-invasive diagnostic tools designed to identify imbalances in the gut microbiome. Utilizing deoxyribonucleic acid sequencing, AnimalBiome's diagnostic services assess the balance of gut bacteria, allowing pet owners to gain insights into their pets' gut health. This information enables tailored supplementation aimed at restoring gut balance, ultimately promoting a healthier and happier life for pets.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Eachday is a digital health management company based in Pittsburgh, Pennsylvania, focused on providing tools and evidence-based techniques for self-managing ADHD. The company's application leverages data and neuroscience to assist users in tracking their behaviors and interests, including task completion, cognitive failures, and self-reported symptoms. By creating personalized profiles for users, Eachday aims to enhance understanding of their condition, visualize time, and develop effective routines. This approach enables individuals to address ADHD symptoms as they arise and alleviate the cognitive load associated with daily activities.

In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring. Phable is marching onward to impact a billion lives over the next 5 years.

Conan MedTech, founded in 2020 and based in Ithaca, New York, specializes in the development of rapid point-of-care diagnostic tests for concussions. The company's innovative system is designed to facilitate real-time concussion detection, enabling sports medicine doctors, athletic coaches, and trainers to make informed decisions during games. By providing advanced and efficient medical assistance, Conan MedTech aims to enhance the diagnosis of mild traumatic brain injuries, ultimately improving patient care and outcomes.

Conan MedTech, founded in 2020 and based in Ithaca, New York, specializes in the development of rapid point-of-care diagnostic tests for concussions. The company's innovative system is designed to facilitate real-time concussion detection, enabling sports medicine doctors, athletic coaches, and trainers to make informed decisions during games. By providing advanced and efficient medical assistance, Conan MedTech aims to enhance the diagnosis of mild traumatic brain injuries, ultimately improving patient care and outcomes.

Midoconline is a telehealth company focused on enhancing wellness through improved access to medical care and preventative measures. It offers a platform that enables patients to connect with healthcare professionals via video consultations, facilitating remote medical advice for non-emergency issues. The mobile application serves as a convenient tool for users seeking medical consultations, thereby promoting better health management and accessibility to healthcare services.

PluriCell wants to positively impact the lives of millions of patients suffering from chronic heart failure condition by injecting healthy bona fide lab-made human heart cells in their failing heart, improve its function and, ultimately, the clinical outcome of the patients. Our tech enables us not only tackle heart diseases, but potentially, many chronic disorders currenly untractable.

QuantumCyte, Inc. is a biotechnology company based in Sunnyvale, California, founded in 2014. It specializes in developing a cell analysis system designed to enhance drug efficacy predictions and advance cancer research. By analyzing large numbers of cells, QuantumCyte aims to deepen the understanding of immune system and cancer biology. The company utilizes artificial intelligence in its pathology technology platform to provide precise cellular data, facilitating single-cell analysis for healthcare providers. Its team comprises experts from various fields, including biology, high technology, and diagnostics, with backgrounds in esteemed organizations such as Stanford and Genentech. QuantumCyte has established strong collaborations with specialists in cancer and genomic sequencing to meet fundamental research needs and ensure the scalability of its products.

Leadoptik is a California-based company operating in stealth mode, focused on developing advanced miniature imaging technology for minimally invasive medical procedures. This innovative technology enhances surgeons' ability to view small objects with improved clarity compared to existing imaging systems, offering 3D navigation capabilities and high-resolution imaging. By facilitating the early detection of cancer in patients, Leadoptik aims to significantly improve surgical outcomes and patient care.

PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.

Chronus Health, Inc. is focused on developing a portable diagnostic platform that delivers rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide real-time diagnoses within minutes. This handheld device significantly enhances the ability of healthcare providers to access actionable data on-site, thereby improving patient outcomes and reducing the time to care. Chronus Health aims to transform the diagnostic process by enabling immediate treatment decisions based on accurate lab results.

Cellens is a spinoff company from Tufts University focused on enhancing cancer screening through noninvasive methods. The company has developed a cell surface scanning platform aimed at assisting oncologists in the detection of bladder cancer. Utilizing atomic force microscopy imaging combined with machine learning, Cellens' technology analyzes physio-biomarkers on cell surfaces derived from urine samples. This innovative approach generates a diagnostics score for bladder cancer, enabling healthcare providers, including oncologists and urologists, to minimize the need for invasive and costly diagnostic procedures. By improving the accuracy of bladder cancer detection, Cellens aims to optimize the patient experience and increase survival rates.

Cellens is a spinoff company from Tufts University focused on enhancing cancer screening through noninvasive methods. The company has developed a cell surface scanning platform aimed at assisting oncologists in the detection of bladder cancer. Utilizing atomic force microscopy imaging combined with machine learning, Cellens' technology analyzes physio-biomarkers on cell surfaces derived from urine samples. This innovative approach generates a diagnostics score for bladder cancer, enabling healthcare providers, including oncologists and urologists, to minimize the need for invasive and costly diagnostic procedures. By improving the accuracy of bladder cancer detection, Cellens aims to optimize the patient experience and increase survival rates.

Hydrostasis develops a hydration monitor system for athletes to reach and maintain peak performance. The wearable sensors measure optimal hydration range based on each individual athlete's body composition and the application notifies athletes before dehydration symptoms impact performance. Hydrostasis is based in San Diego, California.

Solving gout using engineered probiotics

XN Health is a medical device company founded in 2021 and based in Texas, USA. The company specializes in developing innovative healthcare devices aimed at improving the weaning process for mechanically ventilated patients. Its primary product utilizes phrenic nerve stimulation to induce diaphragm contractions, which helps mitigate diaphragm dysfunction often caused by prolonged mechanical ventilation. This technology enables patients to transition off ventilators more quickly and safely, addressing a critical challenge in critical care settings.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on advancing precision medicine through the development of targeted therapeutics. Founded in 2016, the company utilizes a novel bioinformatics platform to identify small ribonucleic acid (sRNA) biomarkers, which are essential for uncovering disease signatures and facilitating drug discovery and repurposing. Their technology employs machine learning to achieve high accuracy in classifying patient samples, making it a valuable tool for identifying custom biomarker panels tailored to individual needs. Gatehouse Bio collaborates with leading drug developers to discover novel drug targets and develop companion diagnostics, with applications validated in areas such as cardiology, neurology, oncology, respiratory diseases, and rare diseases.

Grand Bio is working to improve the efficiency with which cells create their own growth factors. The firm provides supplements that boost growth factors in the medium in which cells live and thrive.

Grand Bio is working to improve the efficiency with which cells create their own growth factors. The firm provides supplements that boost growth factors in the medium in which cells live and thrive.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.

Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases, particularly hyperkalemia, which involves high potassium levels. The company operates a wearable platform that delivers accurate and real-time potassium measurements through interstitial fluid from the skin, providing data closely correlated to blood levels. This innovation is crucial for heart and kidney care, as it enables clinicians and patients to monitor potassium levels effectively. By facilitating timely and informed decision-making regarding medications, diet, and treatment options, Proton Intelligence aims to enhance health outcomes and improve the quality of life for individuals living with chronic conditions.

Proton Intelligence, founded in 2020 and headquartered in Vancouver, Canada, specializes in biomarker monitoring to manage chronic diseases, particularly hyperkalemia, which involves high potassium levels. The company operates a wearable platform that delivers accurate and real-time potassium measurements through interstitial fluid from the skin, providing data closely correlated to blood levels. This innovation is crucial for heart and kidney care, as it enables clinicians and patients to monitor potassium levels effectively. By facilitating timely and informed decision-making regarding medications, diet, and treatment options, Proton Intelligence aims to enhance health outcomes and improve the quality of life for individuals living with chronic conditions.

Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death. The company is based in Palo Alto, California.

Prothegen is a biotechnology company that develops cutting-edge medicines for precisely regulating cell death. The company is based in Palo Alto, California.

Impedans provide you with intelligent sensing platforms for radio-frequency (RF) and plasma process monitoring. Their products find applications in fundamental research, process development, tool design, process control and fault detection and classification (FDC). They serve a wide range of industries, due to the ubiquitous nature of RF and plasma processing, such as semiconductor, vacuum coating, medical device, hard disk and aerospace among many others. Their value proposition is that They provide you with an independent diagnosis of your process health, using intelligent, internet enabled sensing platforms, in conjunction with their vast experience in RF and plasma systems, to help you solve the most complex processing issues.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Every day we flush precious information on our bodies down the toilet. Bisu helps people capture these data and lead healthier, happier lives. Our product is a home health lab that provides personalized advice to help you look, feel and perform at your best, through easy, accurate urine and saliva tests. We are graduates of HAX, the world's leading hardware accelerator, and have won numerous awards including Johnson & Johnson Innovation, MedTech Innovator, the Edison Awards, UK Tech Rocketship Awards and the British Business Awards. At CES 2020 we won the IHS Markit Innovation Award and were named by CNET as one of the top health-tracking devices.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacture of gene-modified cell therapies such as chimeric antigen receptor T cells. The technology is being developed with the help of the Australian National Fabrication Facility. We are alumni of NSW Health, IndieBio, Y Combinator and MBC Biolabs (née QB3@953). We are opening up an office in Sydney and have lab space at Bonneville Labs in Berkeley.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Circadia fuses light science with sleep science to help adjust your body clock. Their flagship products include a non-contact sleep tracker for sleep diagnostics and a portable light therapy device for treatment. The devices sync together for an automatic and customised sleep improvement programme. Team from Imperial College London. Accelerated by HAX. Mentored by Johnson & Johnson Innovation. Launching on Kickstarter in March 2017.

Helex uses its own genomics data, bioinformatics, and intelligent data-driven platform to create, verify, and distribute therapy-specific gRNAs. Founded in 2021 and is based in New York.

Helex uses its own genomics data, bioinformatics, and intelligent data-driven platform to create, verify, and distribute therapy-specific gRNAs. Founded in 2021 and is based in New York.

Rizlab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing practitioners and patients with rapid blood count readings, specifically focusing on white blood cell analysis. Rizlab Health's electronic cytometer and analyzer utilize a cartridge system to quantify key cellular components, such as neutrophils and lymphocytes. This technology enables hospitals and healthcare providers to quickly and affordably monitor patients' white blood counts, which is crucial for diagnosing conditions like sepsis and distinguishing between bacterial and viral infections. By offering a fast, portable, and cost-effective health monitoring solution, Rizlab Health aims to enhance patient care and streamline clinical decision-making processes.

Rizlab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing practitioners and patients with rapid blood count readings, specifically focusing on white blood cell analysis. Rizlab Health's electronic cytometer and analyzer utilize a cartridge system to quantify key cellular components, such as neutrophils and lymphocytes. This technology enables hospitals and healthcare providers to quickly and affordably monitor patients' white blood counts, which is crucial for diagnosing conditions like sepsis and distinguishing between bacterial and viral infections. By offering a fast, portable, and cost-effective health monitoring solution, Rizlab Health aims to enhance patient care and streamline clinical decision-making processes.

Feel Therapeutics, based in San Francisco, is focused on transforming mental health management through its innovative digital precision medicine platform. The company has developed an emotion-sensing wristband and accompanying app that provide continuous monitoring and real-time personalized interventions for individuals experiencing anxiety and depression. This comprehensive solution includes the Feel Emotion Sensor, Feel App, Feel Therapist, and an Educational Program, all designed to leverage evidence-based behavioral techniques such as Cognitive Behavioral Therapy, Mindfulness, and Positive Psychology. By integrating proprietary medical-grade wearables and advanced algorithms, Feel Therapeutics aims to deliver objective data and passive monitoring, ultimately enhancing users' mental well-being and fostering lasting positive emotional habits.

Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.

Advanced Microbubbles Inc specializes in the development of microbubbles, which serve as ultrasound contrast agents for targeted drug delivery. Founded in 2020 and based in Newark, California, the company offers a range of products, including size-isolated microbubbles and biotin- or streptavidin-tagged variants. These microbubbles are designed for applications in ultrasound imaging, noninvasive cancer surgery, and enhancing drug delivery across challenging biological barriers, such as the blood-brain barrier. By focusing on precision drug and gene delivery, Advanced Microbubbles aims to improve treatment outcomes and reduce side effects for patients with neurological conditions and cancer.

EIO Diagnostics Inc. is a Canadian company that focuses on developing innovative solutions for dairy farmers, specifically targeting the early detection of mastitis infections in dairy animals. Founded in 2017 and headquartered in Duncan, Vancouver, the company has created the FirstLook Mastitis detection system, which employs a multispectral sensor to capture images of the udder as animals enter the milk parlor. This technology utilizes artificial intelligence and computer vision to identify early indicators of infection, enabling farmers to take preventive measures. By automating the mastitis detection process, EIO Diagnostics aims to enhance livestock health, improve milk quality, and reduce the labor and costs associated with managing udder infections.

Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.

Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.

RxAll, Inc. is engaged in developing an artificial intelligence-based pharmacy platform that focuses on the authentication and distribution of pharmaceuticals in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) system for real-time drug authentication. Its platform employs a molecular sensor device along with a cloud database containing spectral signatures of various medicines, allowing for non-destructive verification prior to fulfilling pharmacy orders. This technology helps in identifying counterfeit drugs and provides pharmaceutical companies with timely information regarding product authenticity. By streamlining the process of delivering authenticated medicines to hospitals, pharmacies, and patients, RxAll aims to enhance access to high-quality medications while addressing the issue of drug counterfeiting.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

The CareVoice Limited is a Shanghai-based company that develops a mobile-based, data-driven software as a service (SaaS) solution aimed at enhancing the healthcare experience in China. Founded in 2013, the company provides a platform that features community-sourced ratings and recommendations for hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews based on their medical visits, fostering a collaborative environment for individuals undergoing similar treatments. The CareVoice aims to transform healthcare into a more consumer-centric experience, offering tools for insurers to create connected health ecosystems and improve patient engagement. The company also maintains an office in Hong Kong and has garnered support from prominent venture capital and healthcare investors.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

BioROSA Technologies Inc. develops a blood test for autism spectrum disorders (ASD). The company offers diagnostic tools to allow clinicians to determine who is at risk for ASD and enables therapeutic developments through blood-based biomarkers and machine learning tools. BioROSA Technologies Inc. was incorporated in 2018 and is based in Belmont, Massachusetts.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015, that focuses on developing medical devices for blood type analysis and disease detection. The company's flagship product, also named Criam, enables rapid and affordable blood test analysis, allowing users to receive immediate information about their health. This medical device can detect various diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. By positioning itself in the Point-of-Care diagnostic segment, Criam aims to empower individuals with timely health information and contribute to the global monitoring and control of diseases.

Diadem Biotherapeutics is a biotechnology company that focuses on creating bio-therapeutical materials produced using organic means. Diadem develops exosomes to treat chronic inflammatory and auto-immune conditions.

QuantumCyte, Inc. is a biotechnology company based in Sunnyvale, California, founded in 2014. It specializes in developing a cell analysis system designed to enhance drug efficacy predictions and advance cancer research. By analyzing large numbers of cells, QuantumCyte aims to deepen the understanding of immune system and cancer biology. The company utilizes artificial intelligence in its pathology technology platform to provide precise cellular data, facilitating single-cell analysis for healthcare providers. Its team comprises experts from various fields, including biology, high technology, and diagnostics, with backgrounds in esteemed organizations such as Stanford and Genentech. QuantumCyte has established strong collaborations with specialists in cancer and genomic sequencing to meet fundamental research needs and ensure the scalability of its products.

AnimalBiome focuses on improving the gut health of dogs and cats in the United States that suffer from chronic digestive disorders. The company offers microbiome-based supplements and non-invasive diagnostic tools designed to identify imbalances in the gut microbiome. Utilizing deoxyribonucleic acid sequencing, AnimalBiome's diagnostic services assess the balance of gut bacteria, allowing pet owners to gain insights into their pets' gut health. This information enables tailored supplementation aimed at restoring gut balance, ultimately promoting a healthier and happier life for pets.

JointechLabs, Inc. is a company focused on enhancing access to cell-based therapies for healthcare providers and patients. Based in Mount Prospect, Illinois, the company has developed the Mini-Stem System, a closed disposable kit designed for the processing and extraction of stromal vascular cell fractions from human tissue. This innovative medical device allows for the efficient preparation of high-quality injectable fat grafts and fat-derived stem cells, facilitating on-site access to optimized adipose-derived stromal cells (ADSC). By streamlining the process of individualized cell and tissue-based therapies, JointechLabs aims to make these advanced treatments more accessible and cost-effective for use in hospitals, clinics, and local medical offices. Since its incorporation in 2012, the company has been dedicated to improving the efficacy and availability of cell therapies in clinical settings.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

Ria Health is a telehealth provider focused on treating alcohol use disorders through a mobile platform. Founded in 2013 and based in San Francisco, California, the company connects users with addiction specialists for personalized support and guidance. Ria Health employs evidence-based protocols, including medication-assisted treatment, harm reduction, and cognitive behavioral therapy, to assist heavy drinkers seeking to reduce or stop their alcohol consumption. The Ria app facilitates secure, HIPAA-compliant interactions, allowing for video and phone consultations, breathalyzer measurements, and progress tracking. By offering a private and convenient treatment option, Ria Health aims to address the significant gap in care for individuals struggling with alcohol-related issues, ensuring effective and affordable support that aligns with payer objectives.

RayIoT is a platform consisting of devices and software that enable remote health monitoring. The company's solutions are AI-powered and help in predictive analysis of health conditions. Its connected and comprehensive workflow helps in the early detection of abnormal variations in vitals to the management of alerts. rayIoT aims to facilitate decision-making on health conditions by exploring the potential of continuous monitoring of vitals, predominantly breathing rate. The Falls Church, Virginia-located company was founded in 2015.

Impact Biosystems is a developer and creator of adaptive hardware and software solutions for people in the health and fitness space. The company offers hardware connected recovery platform that makes users feel better with custom measurements of their body and make the gamifying and socializing experience adapted to them, thereby enabling athletes of all varieties to uniquely feel better, perform at their peak, and help them live longer. Impact Biosystems' goal is to make athletes of all varieties uniquely feel better, perform at their peak and help them live longer. It was founded in 2020 and is headquartered in Boston, MA.

Hydrostasis develops a hydration monitor system for athletes to reach and maintain peak performance. The wearable sensors measure optimal hydration range based on each individual athlete's body composition and the application notifies athletes before dehydration symptoms impact performance. Hydrostasis is based in San Diego, California.

FluidAI Medical is focused on developing an innovative implantable biochip equipped with biosensors designed to detect post-operative complications, including internal bleeding, fluid leakage, and infections within the abdominal cavity. This advanced biosensor continuously collects data, identifying complications as they arise, and provides real-time notifications to both patients and healthcare providers. Specifically, the device aims to manage risks associated with surgeries by monitoring for anastomotic leakage, which involves gastrointestinal fluid leaking into the abdominal cavity. The biosensor is integrated into a catheter, where it resides within the abdominal cavity, while a monitoring unit remains external. When the biosensor detects changes indicative of a leak, it transmits alerts through the catheter to the external monitor. Data is continuously uploaded to the cloud for further analysis, ensuring timely alerts are sent to patients' smartphones, prompting them to seek medical attention, while offering detailed information to their doctors. Founded in 2014 and based in Kitchener, Canada, FluidAI Medical serves physicians, surgeons, hospitals, and patients with its groundbreaking technology.

DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

DeepSpin GmbH, founded in 2019 and headquartered in Berlin, Germany, specializes in the development of an innovative artificial intelligence (AI)-based magnetic resonance imaging (MRI) system. This next-generation imaging machine is designed to be significantly smaller, lighter, and more affordable than conventional MRI systems. By utilizing generative topological design for its hardware and deep learning algorithms for image processing, DeepSpin aims to enhance the accessibility of medical imaging, making it available to patients worldwide. The company's technology seeks to modernize medical imaging, providing a standard of care that can reach previously underserved medical domains.

Developer of a real-time hydration biosensor platform designed to monitor human bodies at a molecular level. The company's platform is a wearable, non-invasive patch that captures an athlete's sweat and interprets key bio-markers in real-time, starting with electrolytes and total body fluid loss, enabling users to get personalized recommendations that help them improve their performance.

Medical Devices Corner specializes in providing commercial medical products.

Chronus Health, Inc. is focused on developing a portable diagnostic platform that delivers rapid point-of-care lab results, specifically for complete blood count and comprehensive metabolic panel tests. Founded in 2017 and headquartered in California, the company utilizes advanced microfluidics and semiconductor technology, combined with data analytics, to provide real-time diagnoses within minutes. This handheld device significantly enhances the ability of healthcare providers to access actionable data on-site, thereby improving patient outcomes and reducing the time to care. Chronus Health aims to transform the diagnostic process by enabling immediate treatment decisions based on accurate lab results.

Developer of a portable neuroimaging system designed to track and predict recovery of movement function during the rehabilitation of hemiparesis. The company's systems utilize a proprietary optical imaging system, assessment software, and data analytics to measure neural biomarkers and aid neurological rehabilitation, enabling therapists to make sustainable treatment decisions.

Nordetect IVS is a biochemical analysis company based in Copenhagen, Denmark, specializing in the development of biosensors and microfluidic chip technology for precision agriculture. Founded in 2016, the company focuses on nutrient analysis by detecting and quantifying essential macronutrients such as nitrogen, phosphorus, and potassium in soil. Its Lab-on-a-chip devices facilitate reliable and affordable nutrient testing, enabling agronomists and farm-service companies to deliver actionable insights to farmers regarding soil health. By providing results on the nutritional content of soil and recommendations for fertilizer application, Nordetect helps optimize crop performance and supports informed agricultural practices.

Wayfinder Biosciences develops biosensors for ultra-high-throughput screening for high-value molecules. The company's PerfectPath biosensors make invisible molecules visible. These biosensors generate fluorescence based on the concentration of the desired small-molecule — allowing quantification of product titer at high-throughput using fast fluorescence measurements. Wayfinder Biosciences was established in 2021 and is headquartered in San Francisco, CA.

Wayfinder Biosciences develops biosensors for ultra-high-throughput screening for high-value molecules. The company's PerfectPath biosensors make invisible molecules visible. These biosensors generate fluorescence based on the concentration of the desired small-molecule — allowing quantification of product titer at high-throughput using fast fluorescence measurements. Wayfinder Biosciences was established in 2021 and is headquartered in San Francisco, CA.

Feel Therapeutics, based in San Francisco, is focused on transforming mental health management through its innovative digital precision medicine platform. The company has developed an emotion-sensing wristband and accompanying app that provide continuous monitoring and real-time personalized interventions for individuals experiencing anxiety and depression. This comprehensive solution includes the Feel Emotion Sensor, Feel App, Feel Therapist, and an Educational Program, all designed to leverage evidence-based behavioral techniques such as Cognitive Behavioral Therapy, Mindfulness, and Positive Psychology. By integrating proprietary medical-grade wearables and advanced algorithms, Feel Therapeutics aims to deliver objective data and passive monitoring, ultimately enhancing users' mental well-being and fostering lasting positive emotional habits.

Gypsy Bay Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

Gypsy Bay Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.

Dalton Bioanalytics specializes in developing advanced analytical technology aimed at transforming blood analysis into a more efficient and cost-effective process. By digitizing the biochemical composition of blood, the company provides a comprehensive array of actionable health insights, addressing the limitations of traditional laboratory testing. This technology enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules, through a single assay. Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine. Founded in 2019, the company is headquartered in Los Angeles, California.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring. Phable is marching onward to impact a billion lives over the next 5 years.

Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on advancing precision medicine through the development of targeted therapeutics. Founded in 2016, the company utilizes a novel bioinformatics platform to identify small ribonucleic acid (sRNA) biomarkers, which are essential for uncovering disease signatures and facilitating drug discovery and repurposing. Their technology employs machine learning to achieve high accuracy in classifying patient samples, making it a valuable tool for identifying custom biomarker panels tailored to individual needs. Gatehouse Bio collaborates with leading drug developers to discover novel drug targets and develop companion diagnostics, with applications validated in areas such as cardiology, neurology, oncology, respiratory diseases, and rare diseases.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Sequential Skin is a diagnostic platform company targeting skin longevity and aging. Our team specialises in genetics, epigenetics, and the skin microbiome.

Nordetect IVS is a biochemical analysis company based in Copenhagen, Denmark, specializing in the development of biosensors and microfluidic chip technology for precision agriculture. Founded in 2016, the company focuses on nutrient analysis by detecting and quantifying essential macronutrients such as nitrogen, phosphorus, and potassium in soil. Its Lab-on-a-chip devices facilitate reliable and affordable nutrient testing, enabling agronomists and farm-service companies to deliver actionable insights to farmers regarding soil health. By providing results on the nutritional content of soil and recommendations for fertilizer application, Nordetect helps optimize crop performance and supports informed agricultural practices.

Developer of a real-time hydration biosensor platform designed to monitor human bodies at a molecular level. The company's platform is a wearable, non-invasive patch that captures an athlete's sweat and interprets key bio-markers in real-time, starting with electrolytes and total body fluid loss, enabling users to get personalized recommendations that help them improve their performance.

Gatehouse Bio is a biotechnology company based in Waltham, Massachusetts, focused on advancing precision medicine through the development of targeted therapeutics. Founded in 2016, the company utilizes a novel bioinformatics platform to identify small ribonucleic acid (sRNA) biomarkers, which are essential for uncovering disease signatures and facilitating drug discovery and repurposing. Their technology employs machine learning to achieve high accuracy in classifying patient samples, making it a valuable tool for identifying custom biomarker panels tailored to individual needs. Gatehouse Bio collaborates with leading drug developers to discover novel drug targets and develop companion diagnostics, with applications validated in areas such as cardiology, neurology, oncology, respiratory diseases, and rare diseases.

Developer of a nutritional guidance platform designed to provide health plans. The company's platform uses artificial intelligence to create patient surveys and a personalized program as per cultural and lifestyle preferences to provide fresh groceries, enabling users to maintain a healthy and balanced diet at lower costs.

Leadoptik is a California-based company operating in stealth mode, focused on developing advanced miniature imaging technology for minimally invasive medical procedures. This innovative technology enhances surgeons' ability to view small objects with improved clarity compared to existing imaging systems, offering 3D navigation capabilities and high-resolution imaging. By facilitating the early detection of cancer in patients, Leadoptik aims to significantly improve surgical outcomes and patient care.

FoodMarble Digestive Health Ltd., founded in 2016 and based in Dublin, Ireland, develops innovative solutions for digestive health issues affecting nearly one billion people worldwide. The company has created a connected breath analysis device known as AIRE, which helps users identify foods that align with their individual digestive systems. This personal breath analyzer operates based on established clinical tests, enabling users to design personalized diets that improve their digestive well-being. In addition to the AIRE device, FoodMarble provides online application software that assists users in managing their digestive health more effectively. By combining advanced sensor technology with user-friendly software, FoodMarble aims to empower individuals to regain control over their digestion and enhance their quality of life.